BioSpace News Archive

Qualtrics provides a powerful platform for Royal to capture real-time feedback during a key point of the patient experience

Management strengthens its commitment to a successful upcoming market launch of RepliCel’s dermal injector and consumables product line by addition of Damien King

The global kidney transplantation therapeutics market size is poised to grow by USD 1.02 billion during 2019-2023, according to a new report by Technavio, progressing at a CAGR of more than 4% during the forecast period.

Cyxone announced that the company’s CEO Kjell G. Stenberg has for private account increased his ownership in the company through the acquisition of additional share.

ADCendo ApS, a spin-out from the University of Copenhagen and Rigshospitalet, announces having been accepted into the BioInnovation Institute Creation House program.

BR Brands, LLC (“BR Brands”), a consumer packaged goods (“CPG”) company within the global legal cannabis industry, announced today that Mary’s Brands™ co-founder and CEO, Lynn Honderd, has resigned as CEO and will partner with the organization as a strategic advisor.

Major milestone towards go-to market for Distalmotion’s surgical robot Dexter

Epizyme, Inc. announced that Robert Bazemore, president and chief executive officer, will participate in the following September investor conferences

SpringWorks Therapeutics, Inc. announced the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for nirogacestat, an oral, selective, small molecule, gamma-secretase inhibitor, for the treatment of adult patients with progressive, unresectable, recurrent or refractory desmoid tumors or deep fibromatosis.

Eitan Group announced a service partnership with InfuSystem Holdings, Inc., a leading national provider of infusion pumps and related services for the healthcare industry in the U.S. and Canada.